May 27, 2008
NULL
NULL
La Jolla, CA – Salk scientists Samuel L. Pfaff y Andrew Dillin have been selected as Howard Hughes Medical Institute (HHMI) investigators, HHMI announced today. Both join a prestigious group of the nation’s top biomedical researchers who share the coveted title given to science’s most innovative minds.
As new HHMI investigators, Pfaff, a professor in the Gene Expression Laboratory, and Dillin, an associate professor in the Molecular and Cell Biology Laboratory, will be supported for the next five years and encouraged to explore their most creative scientific ideas in their respective fields.
Their appointment raises the number of HHMI investigators conducting research at the Salk Institute to seven.
“Both Sam and Andy are highly deserving of this recognition, which is reserved for a select group of extraordinary scientists,” said Salk Interim President and Nobel laureate Roger Guillemin. “Their recent discoveries and innovative approach to their respective areas of research amply justify their election as Howard Hughes Medical Institute investigators.”
El laboratorio de Pfaff se dedica al estudio del desarrollo embrionario de la médula espinal; en concreto, se centra en investigar cómo se forman las neuronas motoras y cómo establecen sus conexiones predeterminadas entre la médula espinal y los músculos del cuerpo. Estas conexiones son necesarias para todos los movimientos corporales. La alteración de la función de las neuronas motoras suele ser la causa principal de la parálisis derivada de lesiones o enfermedades de la médula espinal.
Under his HHMI appointment, Pfaff will explore a neuronal network in mice that controls rhythmic movement of the hind limbs. The network, called a central pattern generator (CPG), resides in the lower spinal cord and controls gait.
For nearly a century, scientists have known about this network and its relation to limb movement, but little has been understood about the identity and function of the cells in the circuit or the mechanisms responsible for their wiring.
Pfaff’s research of the CPG will provide fundamental insights into how vertebrate locomotion is achieved and could one day translate into new treatments for people with spinal cord injuries or disease.
Dillin’s lab studies the tiny roundworm Ceanorhabditis elegans to understand the process of aging by looking at the hormone most widely recognized for its role in diabetes: insulin. The insulin-signaling pathway in worms is not only almost identical to that found in humans, but Dillin discovered how the insulin pathway controls aging without disrupting other physiological processes.
His lab recently made two important discoveries related to his studies in aging. First, he identified a gene that plays a key role in increasing the life span of mice and other animals kept on extreme calorie-restricted diets.
His lab also discovered the mechanisms that clear away toxic proteins in young healthy brains, mechanisms that, Dillin found, break down with age and lead to protein aggregate build-up, the hallmark of age-related neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s.
Dillin has suggested that the main cause of aging and age-related diseases is our brains’ inability to manage the protein clumps. His lab will continue to work on understanding the aggregate-clearing mechanisms and look for additional cellular pathways with similar protective effects to find clues that may one day help patients with neurodegenerative disease.
“These 56 scientists will bring new and innovative ways of thinking about biology to the HHMI community,” said HHMI President Thomas R. Cech, speaking of the group of researchers elected in the most recent round of appointments. “They are poised to advance scientific knowledge dramatically in the coming years, and we are committed to providing them with the freedom and flexibility to do so.”
El Instituto Salk de Estudios Biológicos en La Jolla, California, es una organización independiente sin fines de lucro dedicada a descubrimientos fundamentales en las ciencias de la vida, la mejora de la salud humana y la formación de futuras generaciones de investigadores. Jonas Salk, M.D., cuya vacuna contra la polio prácticamente erradicó la debilitante enfermedad de la poliomielitis en 1955, inauguró el Instituto en 1965 con un donativo de terrenos de la Ciudad de San Diego y el apoyo financiero de la March of Dimes.
The Howard Hughes Medical Institute, a non-profit medical research organization that ranks as one of the nation’s largest philanthropies, plays a powerful role in advancing biomedical research and science education in the United States. In the past two decades HHMI has made investments of more than $8.3 billion for the support, training, and education of the nation’s most creative and promising scientists.
Oficina de Comunicaciones
Tel.: (858) 453-4100
press@salk.edu
